Foster Jonathan P. bought MBRX
November 12, 2025 · Form 4 insider transaction
Foster Jonathan P. bought 400,000 shares of Moleculin Biotech, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Each restricted stock unit represents a contingent right to receive one shares of Company common stock.; Issued in connection with the reporting person's employment with the Company.; On November 12, 2025, the Board approved this performance based restricted stock unit. The performance based restricted stock units set forth in this table will vest in 20% installments upon the achievement of certain clinical milestones; provided that upon a change of control (as defined in the 2024 Stock Plan) 100% shall vest.